PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,346 | -25.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,859 | +14.2% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,630 | -27.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,814 | +68.8% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -12.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | -60.0% | 2,793 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $20,000 | -23.1% | 2,793 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $26,000 | -3.7% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $27,000 | -6.9% | 2,793 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $29,000 | +3.6% | 2,793 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $28,000 | -3.4% | 2,793 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $29,000 | +20.8% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $24,000 | 0.0% | 2,793 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $24,000 | – | 2,793 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |